PubMed=1701342
Paola Nistico, Raffaele Tecce, Patrizio Giacomini, Andrea Cavallari, Igea D'Agnano, Paul B. Fisher, Pier Giorgio Natali;
Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
Cancer Res. 50:7422-7429(1990)

PubMed=1706743; DOI=10.1111/1523-1747.ep12470092
Margherita Cuomo, Maria Rita Nicotra, Cinzia Apollonj, Rocco Fraioli, Patrizio Giacomini, Pier Giorgio Natali;
Production and characterization of the murine monoclonal antibody 2G10 to a human T4-tyrosinase epitope.
J. Invest. Dermatol. 96:446-451(1991)

PubMed=11266471; DOI=10.1083/jcb.152.4.809; PMCID=PMC2195785
Graca Raposo, Danielle Tenza, Diane M. Murphy, Joanne F. Berson, Michael S. Marks;
Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells.
J. Cell Biol. 152:809-824(2001)

PubMed=12417263; DOI=10.1016/S0006-2952(02)01353-9
Federico De Marco, Marzia Perluigi, Maria Luisa Marcante, Raffaella Coccia, Cesira Foppoli, Carla Blarzino, Maria Anna Rosei;
Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells.
Biochem. Pharmacol. 64:1503-1512(2002)

PubMed=25950383; DOI=10.1111/pcmr.12380
Ikrame Lazar, Emily Clement, Manuelle Ducoux-Petit, Laurence Denat, Vanessa Soldan, Stephanie Dauvillier, Stephanie Balor, Odile Burlet-Schiltz, Lionel Larue, Catherine Muller, Laurence Nieto;
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 28:464-475(2015)

PubMed=28940687; DOI=10.1111/1348-0421.12542
Ko Sato, Oshi Watanabe, Suguru Ohmiya, Fumiko Chiba, Akira Suzuki, Michiko Okamoto, Jiang Younghuang, Akihiro Hata, Hiroyuki Nonaka, Setsuko Kitaoka, Yukio Nagai ...Show all 17 authors... , Kazuhisa Kawamura, Masahiro Hayashi, Satoru Kumaki, Tamio Suzuki, Kazuyoshi Kawakami, Hidekazu Nishimura; Show fewer authors
Efficient isolation of human metapneumovirus using MNT-1, a human malignant melanoma cell line with early and distinct cytopathic effects.
Microbiol. Immunol. 61:497-506(2017)